MENLO PARK, Calif., Aug. 31 /PRNewswire/ -- Transcend Medical, Inc., an ophthalmic device company dedicated to delivering breakthrough advances in the treatment of glaucoma, today announced that it has filled two key positions with the addition of Sean Ianchulev, MD, as Chief Medical Officer and Ginger Clasby as Vice President of Clinical Affairs.
Dr. Ianchulev received his medical degree and a master’s of public health from Harvard University and completed his specialty training at the Doheny Eye Institute, University of Southern California. As a practicing ophthalmic surgeon and glaucoma specialist, he is well published in the field of ophthalmology and currently serves as an Assistant Clinical Professor of Ophthalmology at the University of California at San Francisco (UCSF).
“Ginger and Sean offer us the breadth and depth of relevant experience and leadership skills needed to further develop the Transcend Cypass(TM) System as a therapeutic device to address glaucoma,” said Brian Walsh, President and Chief Executive Officer of Transcend Medical. “Their hires come at a critical time of growth as we embark on our pivotal clinical trial.”
About Transcend Medical, Inc.
Transcend Medical (www.transcendmedical.com) focuses on the research and development of medical devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. It is estimated that nearly four million people in the U.S. and 70 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the U.S. and to over 80 million worldwide by the year 2013. Based in Menlo Park, Calif., Transcend Medical was the first company to be spun out of ForSight Labs (www.forsightlabs.com), an incubator solely focused on ophthalmic innovations.
Transcend Medical, Inc.
